Research Paper Volume 13, Issue 3 pp 3994—4006

Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial

Effect of Ticagrelor/aspirin therapy compared with Clopidogrel/aspirin therapy on high on-treatment platelet reactivity (HOPR) during study time course stratified by metabolizer status. (A) Carriers; (B) Non-carriers.

Figure 2. Effect of Ticagrelor/aspirin therapy compared with Clopidogrel/aspirin therapy on high on-treatment platelet reactivity (HOPR) during study time course stratified by metabolizer status. (A) Carriers; (B) Non-carriers.